[Inhibitory effect of resveratrol on the growth of human colon cancer ls174t cells and its subcutaneously transplanted tumor in nude mice and the mechanism of action]
- PMID: 19538862
[Inhibitory effect of resveratrol on the growth of human colon cancer ls174t cells and its subcutaneously transplanted tumor in nude mice and the mechanism of action]
Abstract
Objective: To explore the effect and mechanism of resveratrol against human colon cancer ls174t cells in vitro and the growth of colon cancer in tumor-bearing nude mice.
Methods: MTT method was used to test the inhibiting effect of resveratrol on the growth and proliferation of ls174t cells. Transmission electron microscopy was used to observe the morphological changes of cell apoptosis, and FCM assay was performed to measure the changes of cell apoptosis rate and cell cycle. RT-PCR method was used to detect the expression of bcl-2 and bax mRNA, and Western blot was used to detect the expression of bcl-2 and bax protein.
Results: MTT test revealed that resveratrol showed significant inhibiting effect on ls174t cells in a concentration- and time-dependent manner. In the concentration range of 25, 50, 100, 200 and 400 micromol/L, the inhibition rate after resveratrol treatment for 24 hours was respectively 1.0%, 9.1%, 17.4%, 27.8% and 66.5%, while the inhibition rate after treatment for 48 hours was respectively 3.6%, 13.7%, 30.2%, 58.4% and 86.1%, and the inhibition rate after treatment for 72 hours was 18.1%, 33.0%, 48.6%, 61.2% and 89.4%, respectively, showing a very significant difference (P < 0.01). Typical ultrastructural apoptotic changes were observed in resveratrol-treated ls174t cells. It was found through FCM assay that resveratrol caused apoptosis in ls174 cells and blocked the cell cycle at S phase. RT-PCR and Western blot test showed that after the treatment of colon cancer cells with resveratrol at different concentrations (25, 50, 100 and 200 micromol/L), the expression level of bcl-2 was decreased, while expression level of bax was increased. The highest inhibition rate was 47.9%. In 200 mg/kg and 800 mg/kg resveratrol treatment groups, the weight of subcutaneously transplanted tumors in nude mice was 4.10 +/- 0.18 g and 3.05 +/- 0.35 g, respectively, the difference was significant compared with that of the control group (P < 0.01).
Conclusion: Resveratrol can inhibit the growth of ls174t cells through apoptosis induction. The mechanism is probably related to inhibition of anti-apoptotic factor bcl-2 and enhancement of expression of apoptotic factor bax.
Similar articles
-
[Effect of total alkaloid of Sophora alopecuroides on SW480 cells and Balb/c nude mice tumor xenograft].Zhong Yao Cai. 2011 Jul;34(7):1090-3. Zhong Yao Cai. 2011. PMID: 22066406 Chinese.
-
[Relationship between apoptotic effect of Resveratrol on KG-1 cells and expression of bcl-2/bax].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Oct;16(5):1026-9. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18928588 Chinese.
-
[Effect of ACBP-S on cell cycle and apoptosis in human gastric cancer cells].Zhonghua Zhong Liu Za Zhi. 2008 Jun;30(6):422-7. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19024515 Chinese.
-
Anti-leukemia effect of resveratrol.Leuk Lymphoma. 2002 May;43(5):983-7. doi: 10.1080/10428190290021669. Leuk Lymphoma. 2002. PMID: 12148909 Review.
-
Lessons from anticancer research might provide new insights into mechanisms of hormone action.Trends Endocrinol Metab. 2001 Apr;12(3):87-9. doi: 10.1016/s1043-2760(01)00380-0. Trends Endocrinol Metab. 2001. PMID: 11306332 Review.
Cited by
-
Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer.Front Pharmacol. 2023 Nov 10;14:1287505. doi: 10.3389/fphar.2023.1287505. eCollection 2023. Front Pharmacol. 2023. PMID: 38026933 Free PMC article. Review.
-
Pterostilbene inhibits pancreatic cancer in vitro.J Gastrointest Surg. 2010 May;14(5):873-9. doi: 10.1007/s11605-010-1164-4. Epub 2010 Feb 6. J Gastrointest Surg. 2010. PMID: 20140535
-
Dietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice.BMC Complement Altern Med. 2013 Jan 8;13:6. doi: 10.1186/1472-6882-13-6. BMC Complement Altern Med. 2013. PMID: 23298290 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials